scPharmaceuticals
Monica Mazziotti has over 20 years of experience in the pharmaceutical industry in various market access roles. Monica is currently the Vice President of Market Access at scPharmaceuticals since October 2020. Prior to this, they worked at AcelRx Pharmaceuticals, Inc. as the Executive Director of Market Access from June 2017 to October 2020. Monica also has experience at Arbor Pharmaceuticals, XenoPort, Inc., Ipsen, PharmaDerm, Biovail, Oscient Pharmaceuticals, Reliant Pharmaceutical, and Schein Pharmaceutical in senior and executive roles related to market access and managed markets. Monica has successfully led teams, developed access strategies, managed accounts, and built relationships with payers and key stakeholders in the pharmaceutical industry.
Monica Mazziotti holds a Bachelor of Arts and Science degree with a dual major in Psychology and Biology from the University of Pittsburgh. No specific start or end year for their education is mentioned.
This person is not in any offices
scPharmaceuticals
scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that, through our proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (IV) delivery—with the goal of transforming infused therapies, advancing patient care, and reducing healthcare costs.